Last reviewed · How we verify

Carbamide Peroxide 10%

Federal University of Minas Gerais · Phase 1 active Small molecule Quality 0/100

Carbamide Peroxide 10% is a Small molecule drug developed by Federal University of Minas Gerais. It is currently in Phase 1 development. Also known as: Group 3 - CP 10%, 10% carbamide peroxide bleaching gel.

Likelihood of approval
9.6% vs 9.6% industry baseline
If approved by FDA: likely 2033–2036
Steps remaining: Phase 2 → Phase 3 → NDA/BLA submission
Confidence: Medium
Why this estimate
  • Baseline phase 1 → approval rate +9.6pp
    Industry-wide phase 1 drugs reach approval ~9.6% of the time (BIO/Informa 2023 industry benchmark across all therapeutic areas).
Predicted approval windows by jurisdiction (conditional on FDA approval)
Regulator Country Likely year Lag vs FDA
FDA US 2033–2036
EMA EU 2034–2037 +0.7 yr
MHRA GB 2034–2037 +0.7 yr
Health Canada CA 2034–2038 +0.9 yr
TGA AU 2034–2038 +1.2 yr
PMDA JP 2034–2038 +1.5 yr
NMPA CN 2035–2039 +2.3 yr
MFDS KR 2034–2038 +1.4 yr
CDSCO IN 2034–2039 +1.8 yr
ANVISA BR 2035–2039 +2.3 yr

Hover any row for the lag rationale. Lag estimates are reduced when the drug has FDA Breakthrough or EMA PRIME designation (sponsors file globally in parallel).

Estimate based on the BIO/Informa industry phase transition rates plus per-drug modifiers for therapeutic area, sponsor type, FDA designations, mechanism, and trial design. Per-jurisdiction lags from Tufts CSDD international approval studies. Not investment, clinical or regulatory advice. Methodology: /methodology#likelihood.

At a glance

Generic nameCarbamide Peroxide 10%
Also known asGroup 3 - CP 10%, 10% carbamide peroxide bleaching gel
SponsorFederal University of Minas Gerais
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Carbamide Peroxide 10%

What is Carbamide Peroxide 10%?

Carbamide Peroxide 10% is a Small molecule drug developed by Federal University of Minas Gerais.

Who makes Carbamide Peroxide 10%?

Carbamide Peroxide 10% is developed by Federal University of Minas Gerais (see full Federal University of Minas Gerais pipeline at /company/federal-university-of-minas-gerais).

Is Carbamide Peroxide 10% also known as anything else?

Carbamide Peroxide 10% is also known as Group 3 - CP 10%, 10% carbamide peroxide bleaching gel.

What development phase is Carbamide Peroxide 10% in?

Carbamide Peroxide 10% is in Phase 1.

What are the side effects of Carbamide Peroxide 10%?

Common side effects of Carbamide Peroxide 10% include Tooth Sensitivity (Score of <3).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing